- Home
- QSI vs PRQR Comparison
QSI vs PRQR Comparison
Compare QSI & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QSI
- PRQR
- Stock Information
- Founded
- QSI 2013
- PRQR 2012
- Country
- QSI United States
- PRQR Netherlands
- Employees
- QSI N/A
- PRQR N/A
- Industry
- QSI Biotechnology: Pharmaceutical Preparations
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- QSI Health Care
- PRQR Health Care
- Exchange
- QSI Nasdaq
- PRQR Nasdaq
- Market Cap
- QSI 208.6M
- PRQR 232.8M
- IPO Year
- QSI N/A
- PRQR 2014
- Fundamental
- Price
- QSI $1.09
- PRQR $2.27
- Analyst Decision
- QSI Strong Buy
- PRQR Strong Buy
- Analyst Count
- QSI 3
- PRQR 8
- Target Price
- QSI $2.38
- PRQR $8.88
- AVG Volume (30 Days)
- QSI 6.1M
- PRQR 360.2K
- Earning Date
- QSI 08-05-2025
- PRQR 11-06-2025
- Dividend Yield
- QSI N/A
- PRQR N/A
- EPS Growth
- QSI N/A
- PRQR N/A
- EPS
- QSI N/A
- PRQR N/A
- Revenue
- QSI $3,412,000.00
- PRQR $20,129,184.00
- Revenue This Year
- QSI $45.62
- PRQR N/A
- Revenue Next Year
- QSI $218.03
- PRQR N/A
- P/E Ratio
- QSI N/A
- PRQR N/A
- Revenue Growth
- QSI 100.47
- PRQR 8.65
- 52 Week Low
- QSI $0.61
- PRQR $1.07
- 52 Week High
- QSI $5.77
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- QSI 36.82
- PRQR 52.58
- Support Level
- QSI $0.95
- PRQR $2.21
- Resistance Level
- QSI $1.14
- PRQR $2.50
- Average True Range (ATR)
- QSI 0.07
- PRQR 0.15
- MACD
- QSI 0.02
- PRQR 0.01
- Stochastic Oscillator
- QSI 53.70
- PRQR 52.04
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.